Affiliation:
1. Department of Neurosurgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou,
510095, China
2. Department of Neurosurgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, China
Abstract
Background:
Human brain tumor glioblastoma (GBM) is the most hostile malignancy,
currently lacking a successful cure and good prognosis.
Objective:
To examine the anticancer effects of syringic acid (SA) on human cancer GBM cells.
Methodology:
The different doses of SA were added to GBM cells to study its effect on viability,
invasion, relocation, apoptosis, and mRNA and protein levels. Hence, we explored the antiproliferative,
anti-invasive, and apoptotic activity of SA on GBM human U-251 cells.
Results:
MTT assay and live/dead assay revealed the anti-proliferative activity of SA on U-251
glioma cells. Apoptotic activity of SA was shown by DAPI staining, caspase-3, Bax, and Bcl-2
mRNA expressions. The cell cycle regulation was also confirmed by reducing the mRNA expression
of cyclinD1, CDK4, and CDK6. Treatment of SA with U-251 cells suppressed MMPs expressions
and enhanced TIMPs protein levels.
Conclusion:
Our findings put forward that SA could prevent GBM cells’ invasion and relocation.
SA is an ideal neuroprotective agent for controlling brain malignancy.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Biotechnology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献